Literature DB >> 31271889

SOX4: Epigenetic regulation and role in tumorigenesis.

Hamza Hanieh1, Emad A Ahmed2, Radhakrishnan Vishnubalaji3, Nehad M Alajez3.   

Abstract

Sex-determining region Y-related (SRY) high-mobility group box 4 (SOX4) is a member of the group C subfamily of SOX transcription factors and promotes tumorigenesis by endowing cancer cells with survival, migratory, and invasive capacities. Emerging evidence has highlighted an unequivocal role for this transcription factor in mediating various signaling pathways involved in tumorigenesis, epithelial-to-mesenchymal transition (EMT), and tumor progression. During the last decade, numerous studies have highlighted the epigenetic interplay between SOX4-targeting microRNAs (miRNAs), long noncoding RNAs (lncRNAs) and SOX4 and the subsequent modulation of tumorigenesis, invasion and metastasis. In this review, we summarize the current state of knowledge about the role of SOX4 in cancer development and progression, the epigenetic regulation of SOX4, and the potential utilization of SOX4 as a diagnostic and prognostic biomarker and its depletion as a therapeutic target.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; EMT; Epigenetic regulation; SOX4; lncRNA; microRNA

Year:  2019        PMID: 31271889     DOI: 10.1016/j.semcancer.2019.06.022

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  29 in total

1.  Novel acetylation-related gene signatures for predicting the prognosis of patients with colorectal cancer.

Authors:  Zhuang Jing; Feng Ziwang; Wu Yinhang; Zhou Yani; Chu Jian; Wu Jingwen; Han Shuwen
Journal:  Hum Cell       Date:  2022-05-23       Impact factor: 4.174

Review 2.  LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer.

Authors:  Yan Ma; Yang Di; Qiuyue Li; Qilin Zhan; Xiaomeng He; Shanshan Liu; Heng Zou; Christopher Corpe; Litian Chen; Jin Wang
Journal:  Discov Oncol       Date:  2022-07-11

3.  Circular RNA drives resistance to anti-PD-1 immunotherapy by regulating the miR-30a-5p/SOX4 axis in non-small cell lung cancer.

Authors:  Jing Wu; Meng-Xuan Zhu; Ke-Sang Li; Ling Peng; Peng-Fei Zhang
Journal:  Cancer Drug Resist       Date:  2022-03-25

4.  Circular RNA UBAP2 contributes to tumor growth and metastasis of cervical cancer via modulating miR-361-3p/SOX4 axis.

Authors:  Lingli Meng; Xiupeng Jia; Wenying Yu; Chunnian Wang; Jie Chen; Fenglei Liu
Journal:  Cancer Cell Int       Date:  2020-07-31       Impact factor: 5.722

5.  D-EE: Distributed software for visualizing intrinsic structure of large-scale single-cell data.

Authors:  Shaokun An; Jizu Huang; Lin Wan
Journal:  Gigascience       Date:  2020-11-11       Impact factor: 6.524

6.  XIST promotes cell proliferation and invasion by regulating miR-140-5p and SOX4 in retinoblastoma.

Authors:  Yuhui Wang; Dahong Sun; Ying Sheng; Hong Guo; Fanchun Meng; Tingting Song
Journal:  World J Surg Oncol       Date:  2020-03-03       Impact factor: 2.754

7.  hsa_circ_0001018 promotes papillary thyroid cancer by facilitating cell survival, invasion, G1/S cell cycle progression, and repressing cell apoptosis via crosstalk with miR-338-3p and SOX4.

Authors:  Qiang Luo; Feng Guo; Qingfeng Fu; Guoqing Sui
Journal:  Mol Ther Nucleic Acids       Date:  2021-02-24       Impact factor: 8.886

8.  Silencing of circRNA circ_0001666 Represses EMT in Pancreatic Cancer Through Upregulating miR-1251 and Downregulating SOX4.

Authors:  Rundong Zhang; Wanli Zhu; Chenchao Ma; Kaixing Ai
Journal:  Front Mol Biosci       Date:  2021-05-13

9.  HLA complex group 11 is involved in colorectal carcinoma cisplatin resistance via the miR-214-5p/SOX4 axis.

Authors:  Jianping Xie; Jiaping Zhu; Jie Pang; Yaping Ma
Journal:  Oncol Lett       Date:  2021-05-19       Impact factor: 2.967

10.  Circ_0124644 Serves as a ceRNA for miR-590-3p to Promote Hypoxia-Induced Cardiomyocytes Injury via Regulating SOX4.

Authors:  Juan Tan; Weinan Pan; Huilin Chen; Yafang Du; Peiyong Jiang; Dianmei Zeng; Jie Wu; Kuang Peng
Journal:  Front Genet       Date:  2021-06-25       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.